Literature DB >> 17304105

The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis.

Nicholas Wisnoski1, Chun-Shiang Chung, Yaping Chen, Xin Huang, Alfred Ayala.   

Abstract

Studies have indicated that there is a development of generalized immune dysfunction after septic insult. However, the mechanisms responsible for these changes remain unclear. Recently, accumulating evidence shows that several lymphocyte subpopulations such as NKT-, CD4(+)-Th2-T-, CD8(+)-T-, gammadelta-T-, and CD4+ CD25+ T regulatory cells are capable of actively contributing to the induction of septic immune suppression. Thus, our aim was to investigate the contribution of CD4+ CD25+ cells to the immune dysfunction seen in sepsis. To study this, C57BL/6J, C57BL/6-Il6(tm1Kopf) (interleukin [IL] 6 -/-), and C57BL/6-Il10(tm1Cgn) (IL-10 -/-) mice were subjected to cecal ligation and puncture (CLP) or sham operations. Twenty-four hours later, blood was collected, and splenocytes were isolated. Phenotypic expression of CD4/CD25 (by fluorescence-activated cell sorter), cell proliferation (presented as proliferation index = [with anti-CD3]/[without anti-CD3]), and immune suppressive capacity (by in vitro add-back experiments) were assessed. The results indicate a marked elevation in CD4+ CD25+ cell levels and their proliferation index after sepsis in background mice. CD4+ CD25- cells from sham and CLP mice proliferated equally. However, coculture of CD4+ CD25- with CD4+ CD25+ cells suppressed their proliferation in both sham and CLP mice. Depletion of CD25+ cells in vivo before CLP markedly restored CD4+ CD25- proliferative capacity and Th1 cytokine release while not altering plasma proinflammatory cytokine levels. Subsequently, IL-6 -/- and IL-10 -/- mice were used to elucidate the possible mediator(s) regulating the changes seen after sepsis. Although CD4+ CD25+ cells increased after septic insult in both C57BL/6J and IL-6 -/- mice, this was not observed in IL-10 -/- mice. Similarly, in vitro proliferation studies showed that proliferation index increased in CD4+ CD25+ cells from septic C57BL/6J and IL6 -/- mice, but it remained the same in IL-10 -/- mice. Surprisingly, depletion of CD25+ cells before inducing sepsis did not alter septic mortality. Together, these findings suggest that although CD4+ CD25+ T regulatory cells induced by IL-10 seem to contribute to aspects of sepsis-induced lymphoid immune suppression, the oblation of CD25+ cells does not provide a survival advantage or disadvantage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304105      PMCID: PMC1805637          DOI: 10.1097/01.shk.0000239780.33398.e4

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  31 in total

Review 1.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Authors:  Rebecca S McHugh; Matthew J Whitters; Ciriaco A Piccirillo; Deborah A Young; Ethan M Shevach; Mary Collins; Michael C Byrne
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

3.  MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis.

Authors:  G Y Song; C S Chung; I H Chaudry; A Ayala
Journal:  Am J Physiol Cell Physiol       Date:  2001-08       Impact factor: 4.249

Review 4.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

5.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  T regulatory cells 1 inhibit a Th2-specific response in vivo.

Authors:  F Cottrez; S D Hurst; R L Coffman; H Groux
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis.

Authors:  Mario Perl; Chun-Shiang Chung; Joanne Lomas-Neira; Tina-Marie Rachel; Walter L Biffl; William G Cioffi; Alfred Ayala
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

8.  Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.

Authors:  Yona Kalechman; Uzi Gafter; Rivka Gal; Galit Rushkin; Donghong Yan; Michael Albeck; Benjamin Sredni
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Certified professionals: CD4(+)CD25(+) suppressor T cells.

Authors:  E M Shevach
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

Authors:  K H Sonoda; M Exley; S Snapper; S P Balk; J Stein-Streilein
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  59 in total

1.  Human labour is associated with altered regulatory T cell function and maternal immune activation.

Authors:  N M Shah; L F Edey; N Imami; M R Johnson
Journal:  Clin Exp Immunol       Date:  2019-11-03       Impact factor: 4.330

2.  Partial Depletion of Regulatory T Cells Enhances Host Inflammatory Response Against Acute Pseudomonas aeruginosa Infection After Sepsis.

Authors:  Zhi-Qiang Hu; Yong-Ming Yao; Wei Chen; Jia-Lan Bian; Lin-Jun Zhao; Long-Wang Chen; Guang-Liang Hong; Zhong-Qiu Lu; Guang-Ju Zhao
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

4.  The kinetics of T regulatory cells in shock: beyond sepsis.

Authors:  Eirini Christaki; Eleni Patrozou
Journal:  Crit Care       Date:  2010-03-19       Impact factor: 9.097

Review 5.  The role of regulatory T cells in immune dysfunction during sepsis.

Authors:  Chao Cao; Tao Ma; Yan-Fen Chai; Song-Tao Shou
Journal:  World J Emerg Med       Date:  2015

6.  Glucocorticoids regulate the proliferation of T cells via miRNA-155 in septic shock.

Authors:  Ying Chen; Guang Wang; Zhongmin Liu; Shiji Wang; Yushan Wang
Journal:  Exp Ther Med       Date:  2016-10-20       Impact factor: 2.447

7.  Immune cell populations and cytokine production in spleen and mesenteric lymph nodes after laparoscopic surgery versus conventional laparotomy in mice.

Authors:  Ueli Moehrlen; Anja Lechner; Monika Bäumel; Karin Dostert; Johann Röhrl; Martin Meuli; Daniela N Männel; Jürg Hamacher
Journal:  Pediatr Surg Int       Date:  2012-03-17       Impact factor: 1.827

8.  Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner.

Authors:  Alexandra C Bolognese; Archna Sharma; Weng-Lang Yang; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

9.  Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Vaidehi R Chowdhary; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

10.  Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study.

Authors:  Li-Feng Huang; Yong-Ming Yao; Ning Dong; Yan Yu; Li-Xin He; Zhi-Yong Sheng
Journal:  Crit Care       Date:  2010-01-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.